Aliskiren, the first direct renin inhibitor for treatment of hypertension: the path of its development
about
Combined renin inhibition/(pro)renin receptor blockade in diabetic retinopathy--a study in transgenic (mREN2)27 rats.Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination.Inhibition of renin and the (pro)renin receptor system.Renin-angiotensin system blocking drugs.Drug discovery effectiveness from the standpoint of therapeutic mechanisms and indications.Novel renin inhibitors containing derivatives of N-alkylleucyl-β-hydroxy-γ-amino acids.
P2860
Aliskiren, the first direct renin inhibitor for treatment of hypertension: the path of its development
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Aliskiren, the first direct re ...... n: the path of its development
@ast
Aliskiren, the first direct re ...... n: the path of its development
@en
Aliskiren, the first direct re ...... n: the path of its development
@nl
type
label
Aliskiren, the first direct re ...... n: the path of its development
@ast
Aliskiren, the first direct re ...... n: the path of its development
@en
Aliskiren, the first direct re ...... n: the path of its development
@nl
prefLabel
Aliskiren, the first direct re ...... n: the path of its development
@ast
Aliskiren, the first direct re ...... n: the path of its development
@en
Aliskiren, the first direct re ...... n: the path of its development
@nl
P2093
P356
P1476
Aliskiren, the first direct re ...... n: the path of its development
@en
P2093
P356
10.4103/0022-3859.93250
P407
P50
P577
2012-01-01T00:00:00Z